Consumables · Infection Control · CSSD
Bring barrier protection, sterile packaging, surface disinfection, and vascular-access consumables into one evidence review before a materials committee commits volume or GPO placement.
Six evaluation gates
Each gate maps to a document request, not a marketing claim. Confirm the current IFU, lot evidence, and regional labeling before award.
Where labeled, review SAL 10−6 process validation under ISO 11135 (EO) or ISO 11137 (gamma/e-beam), plus packaging integrity under ISO 11607.
Capture UDI-DI, UDI-PI, lot, expiry, and barcode format so receiving, CSSD, and recall drills share one identity model.
ISO 10993 endpoints apply to patient-contacting materials. Skin-contact gloves and wound dressings need different evidence packages than surface wipes.
Single-use convenience shifts waste and purchasing cadence; reusable paths add AAMI ST91 labor, chemical compatibility, and maximum-cycle statements.
ISO 13485 certificate scope, design history file (DHF) excerpts, and device master record (DMR) controls must match the SKU under review.
Complaint trending, PMS plans, field-action templates, and lot-level recall lookup close the loop after go-live.
Procurement workbench
Figures below are planning ranges from industry practice, not specifications for every Fujifilm reference. Expand a family, then confirm the IFU.
| ASTM / EN filtration | Verify bacterial filtration efficiency and differential pressure against the labeled ASTM level or EN 14683 type |
|---|---|
| Glove AQL | Plan against labeled AQL and tensile strength; confirm powder-free and chemotherapy permeation claims separately |
| Allergen controls | Document latex status, accelerator chemistry disclosures, and biocompatibility endpoints for prolonged skin contact |
| Boundary | Fit testing, donning technique, and change cadence dominate real-world exposure risk |
| Packaging standard | ISO 11607 design and process validation; seal strength and microbial barrier checks |
|---|---|
| Cycle compatibility | Steam 121°C / 134°C, EO, hydrogen peroxide gas plasma — confirm labeled modality only |
| Indicator class | Chemical indicator class and biological indicator organism stated on the IFU, not assumed by color |
| Boundary | Wet packs, overloading, and incomplete drying invalidate visual pass signals |
| Contact time | Labeled wet-contact minutes for the organism claim under review; dry wipe-downs do not count |
|---|---|
| Material compatibility | Check plastics, displays, and soft metals against the chemical family before fleet-wide rollout |
| EPA / market label | Confirm registration or market authorization for the specific SKU and country |
| Boundary | Organic soil load, incorrect dilution, and incomplete coverage reduce efficacy |
| Intended use | Wound depth, exudate level, catheter gauge, and dwell-time statements govern SKU selection |
|---|---|
| Sterility & shelf life | Terminal sterilization modality, packaging integrity, and expiry dating must match storage practice |
| Traceability | UDI, lot, and complaint coding for insertion-site events and dressing changes |
| Boundary | Clinical protocols and nursing competency drive outcomes more than catalog photography |
Care-setting routes
Steam, EO, and low-temperature cycles; pouch inventory; indicator QC; wet-pack reduction.
Barrier packs, glove change cadence, procedure trays, and turnover disinfection timing.
Compact sterile storage, CMS Conditions for Coverage, and rapid case-cart replenishment.
Point-of-care wipe protocols, examination gloves, and low-volume sterilization documentation.
F-tag 880 infection-control programs, PPE stock depth, and outbreak response kits.
Bench disinfection contact times, glove AQL, and sharps / spill-kit readiness.
Scroll horizontally to compare care settings →
Documentation checkpoints
Each mark is a document request. A 510(k) clearance is not the same pathway as PMA, and CE marking must cite MDR 2017/745 where applicable.
Evidence packet
Population, environment, operator, contraindications, and labeled claims for the exact SKU.
Sterilization modality, packaging tests, shelf-life evidence, and acceptance thresholds.
UDI structure, lot genealogy, complaint coding, and recall drill artifacts.
PMS inputs, field-action templates, waste handling, and take-back or disposal notes.
Next step
Share monthly usage estimates, sterilization modality, target market, and the documentation set your value-analysis committee requires. No protected health information is needed for the initial review.